Lanfear Dennis M

CIK 00014208222 companiesREDWOOD CITY, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001420822

Recent Transactions

50 trades

Tax Payment
Coherus Oncology, Inc.$CHRS
Common Stock
2026-01-20$1.55/sh−11,839→ 673,235 total
Award
Coherus Oncology, Inc.$CHRS
Stock Option (Right to Buy)
2025-05-07+375,000→ 375,000 total
Tax Payment
Coherus Oncology, Inc.$CHRS
Common Stock
2025-01-20$1.39/sh−11,810→ 685,074 total
Award
Coherus Oncology, Inc.$CHRS
Stock Option (Right to Buy)
2025-01-10+575,000→ 575,000 total
Tax Payment
Coherus Oncology, Inc.$CHRS
Common Stock
2025-01-04$1.66/sh−11,810→ 696,884 total
Award
Coherus Oncology, Inc.$CHRS
Stock Option (Right to Buy)
2024-07-22+196,500→ 196,500 total
Tax Payment
Coherus Oncology, Inc.$CHRS
Common Stock
2024-01-20$2.44/sh−11,218→ 708,694 total
Award
Coherus Oncology, Inc.$CHRS
Stock Option (Right to Buy)
2024-01-05+575,000→ 575,000 total
Tax Payment
Coherus Oncology, Inc.$CHRS
Common Stock
2024-01-04$2.92/sh−11,781→ 719,912 total
Exercise/Conversion
Coherus Oncology, Inc.$CHRS
Stock Option (Right to Buy)
2023-11-22−299,940→ 0 total
Exercise/Conversion
Coherus Oncology, Inc.$CHRS
Common Stock
2023-11-22$1.42/sh+41,000→ 695,853 total
Sale
Coherus Oncology, Inc.$CHRS
Common Stock
2023-11-22$2.02/sh−223,100→ 731,693 total
Exercise/Conversion
Coherus Oncology, Inc.$CHRS
Common Stock
2023-11-22$1.42/sh+258,940→ 954,793 total
Award
Coherus Oncology, Inc.$CHRS
Stock Option (Right to Buy)
2023-06-13+225,000→ 225,000 total
Award
Coherus Oncology, Inc.$CHRS
Common Stock
2023-01-20+86,250→ 654,853 total
Award
Coherus Oncology, Inc.$CHRS
Stock Option (Right to Buy)
2023-01-05+402,500→ 402,500 total
Tax Payment
Coherus Oncology, Inc.$CHRS
Common Stock
2023-01-04$9.87/sh−10,905→ 568,603 total
Gift
Coherus Oncology, Inc.$CHRS
Common Stock
2022-12-30−4,000→ 432,684 total
Award
Coherus Oncology, Inc.$CHRS
Common Stock
2022-01-04+86,250→ 579,508 total
Award
Coherus Oncology, Inc.$CHRS
Stock Option (Right to Buy)
2022-01-04+402,500→ 402,500 total
Gift
Coherus Oncology, Inc.$CHRS
Common Stock
2021-11-17−10,000→ 436,684 total
Exercise/Conversion
Coherus Oncology, Inc.$CHRS
Stock Option (Right to Buy)
2021-06-08−31,054→ 0 total
Sale
Coherus Oncology, Inc.$CHRS
Common Stock
2021-06-08$13.56/sh−31,054→ 493,258 total
Exercise/Conversion
Coherus Oncology, Inc.$CHRS
Common Stock
2021-06-08$0.42/sh+31,054→ 524,312 total
Exercise/Conversion
Coherus Oncology, Inc.$CHRS
Stock Option (Right to Buy)
2021-06-06−300,000→ 31,054 total
Exercise/Conversion
Coherus Oncology, Inc.$CHRS
Common Stock
2021-06-06$0.42/sh+300,000→ 493,258 total
Award
Coherus Oncology, Inc.$CHRS
Stock Option (Right to Buy)
2021-02-01+125,000→ 125,000 total
Award
Coherus Oncology, Inc.$CHRS
Stock Option (Right to Buy)
2021-01-23+500,000→ 500,000 total
Exercise/Conversion
Coherus Oncology, Inc.$CHRS
Common Stock, $0.0001 par value
2020-07-01$0.01/sh+29,994→ 193,258 total
Exercise/Conversion
Coherus Oncology, Inc.$CHRS
Stock Option (Right to Buy)
2020-07-01−29,994→ 0 total
Tax Payment
Coherus Oncology, Inc.$CHRS
Common Stock, $0.0001 par value
2020-01-10$17.73/sh−21,516→ 163,264 total
Award
Coherus Oncology, Inc.$CHRS
Stock Option (Right to Buy)
2020-01-10+500,000→ 500,000 total
Award
Coherus Oncology, Inc.$CHRS
Common Stock, $0.0001 par value
2020-01-10+59,763→ 184,780 total
Sale
Coherus Oncology, Inc.$CHRS
Common Stock, $0.0001 par value
2019-11-21$18.56/sh−12,500→ 446,684 total
Sale
Coherus Oncology, Inc.$CHRS
Common Stock, $0.0001 par value
2019-11-20$18.00/sh−825,000→ 459,184 total
Sale
Coherus Oncology, Inc.$CHRS
Common Stock, $0.0001 par value
2019-05-30$19.49/sh−32,398→ 1,284,184 total
Award
Coherus Oncology, Inc.$CHRS
Common Stock, $0.0001 par value
2019-01-11+50,265→ 142,884 total
Tax Payment
Coherus Oncology, Inc.$CHRS
Common Stock, $0.0001 par value
2019-01-11$12.37/sh−17,867→ 125,017 total
Award
Coherus Oncology, Inc.$CHRS
Stock Option (Right to Buy)
2019-01-11+450,000→ 450,000 total
Sale
Coherus Oncology, Inc.$CHRS
Common Stock, $0.0001 par value
2018-05-16$16.26/sh−20,984→ 1,316,582 total
Award
Coherus Oncology, Inc.$CHRS
Stock Option (Right to Buy)
2018-02-01+400,000→ 400,000 total
Award
Coherus Oncology, Inc.$CHRS
Common Stock, $0.0001 par value
2017-12-15+20,984→ 92,619 total
Award
Coherus Oncology, Inc.$CHRS
Stock Option (Right to Buy)
2017-08-06+200,000→ 200,000 total
Sale
Coherus Oncology, Inc.$CHRS
Common Stock, $0.0001 par value
2016-09-21$31.75/sh−50→ 1,337,566 total
Sale
Coherus Oncology, Inc.$CHRS
Common Stock, $0.0001 par value
2016-09-20$31.75/sh−4,010→ 1,337,616 total
Sale
Coherus Oncology, Inc.$CHRS
Common Stock, $0.0001 par value
2016-09-16$31.79/sh−2,900→ 1,341,626 total
Award
Coherus Oncology, Inc.$CHRS
Stock Option (Right to Buy)
2016-05-11+323,889→ 323,889 total
Sale
Coherus Oncology, Inc.$CHRS
Common Stock, $0.0001 par value
2015-11-30$31.75/sh−400→ 1,344,526 total
Award
Coherus Oncology, Inc.$CHRS
Stock Option (Right to Buy)
2015-05-21+35,000→ 35,000 total
Award
Coherus Oncology, Inc.$CHRS
Stock Option (Right to Buy)
2015-04-02+150,000→ 150,000 total

Companies

Recent Filings

Address

C/O COHERUS ONCOLOGY, INC. 333 TWIN DOLPHIN DRIVE, SUITE 600

REDWOOD CITY, CA, 94065

View on SEC.gov